Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543950 | NSE: YATHARTH | Hospital & Healthcare Services | Small Cap

Yatharth Hospital Share Price

678.40 -6.15 -0.90%
as on 05-Dec'25 12:04

Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543950 | NSE: YATHARTH | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Yatharth Hospital

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Yatharth Hospital & Trauma Care Services stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
71.76
Market Cap:
6,595.9 Cr.
52-wk low:
345.4
52-wk high:
843

Is Yatharth Hospital & Trauma Care Services Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Yatharth Hospital: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Yatharth Hospital & Trauma Care Services Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.1%9.7%17.9%37.2%37.3%21.1%10.4%-
Value Creation
Index
-0.5-0.30.31.81.70.5-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 102133165299372420454490
Sales YoY Gr.-30.3%24.1%81.3%24.4%13%8.2%-
Adj EPS 0.40.11.96.49.89.89.19.5
YoY Gr.--72.7%1466.7%241.5%52.7%-0.2%-7%-
BVPS (₹) 8.58.610.617.126.997.5158.3163.2
Adj Net
Profit
2.90.812.342.164.28487.792
Cash Flow from Ops. 1923.525.826.825.61688.7-
Debt/CF from Ops. 6.34.844.14.40.20-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA27.9%15%8.2%
Adj EPS NA137.7%12.3%-7%
BVPSNA79%110.2%62.4%
Share Price - - - 9.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
5.21.419.646.544.616.67.45.9
Op. Profit
Mgn %
19.423.72728.528.628.328.725.6
Net Profit
Mgn %
2.90.67.514.117.32019.318.8
Debt to
Equity
2.221.510.7000
Working Cap
Days
0758697128260473291
Cash Conv.
Cycle
0924426188118276

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Yatharth Hospital & Trauma Care Services Ltd.

Standalone Consolidated
TTM EPS (₹) 9.5 15.8
TTM Sales (₹ Cr.) 490 988
BVPS (₹.) 163.2 175.3
Reserves (₹ Cr.) 1,477 1,592
P/BV 4.19 3.91
PE 71.76 43.26
From the Market
52 Week Low / High (₹) 345.35 / 843.00
All Time Low / High (₹) 304.00 / 843.00
Market Cap (₹ Cr.) 6,596
Equity (₹ Cr.) 96.4
Face Value (₹) 10
Industry PE 90.5

Management X-Ray of Yatharth Hospital:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.180.000.000.000.0013.8113.8115.33
* Pledged shares as % of Promoter's holding (%)

Valuation of Yatharth Hospital - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Yatharth Hospital

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales102133165299372420454
Operating Expenses 82101120214265301324
Manufacturing Costs48505090123148160
Material Costs9131828293745
Employee Cost 18223257576979
Other Costs 7172139574640
Operating Profit 20314585106119130
Operating Profit Margin (%) 19.4%23.7%27.0%28.5%28.6%28.3%28.7%
Other Income 001121412
Interest 71413131064
Depreciation 8151413131319
Exceptional Items 0000000
Profit Before Tax 63186086113119
Tax 32518212932
Profit After Tax 311242648488
PAT Margin (%) 2.9%0.6%7.5%14.1%17.3%20.0%19.3%
Adjusted EPS (₹)0.40.11.96.49.89.89.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 5656691121768371,525
Share Capital 16161666668696
Reserves 394053461117511,429
Minority Interest0000000
Debt12010296858620
Long Term Debt12010292707620
Short Term Debt004151000
Trade Payables12111316111211
Others Liabilities 10323473542839
Total Liabilities 1972022112863268781,575

Fixed Assets

Gross Block191194204212223248296
Accumulated Depreciation44597290102116134
Net Fixed Assets 146134132122121133161
CWIP 000000153
Investments 283334474767234
Inventories2332349
Trade Receivables1318327686143171
Cash Equivalents 011213227299
Others Assets 712103657304547
Total Assets 1972022112863268781,575

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 19242627261689
PBT 83186086113119
Adjustment 1128272521610
Changes in Working Capital 2-5-18-49-49-67-28
Tax Paid -2-2-0-9-32-36-13
Cash Flow From Investing Activity -39-8-4-18-9-167-298
Capex -1-3-3-6-8-34-205
Net Investments -12-5-0-13-0-125-9
Others -260-100-8-83
Cash Flow From Financing Activity 21-20-23-7-6241347
Net Proceeds from Shares 40000577600
Net Proceeds from Borrowing 0-6000-74-2
Interest Paid -5-13-12-12-9-4-1
Dividend Paid 0000000
Others 220-1142-258-251
Net Cash Flow 2-4-111189138

Finance Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.231.4219.6346.4944.5916.587.42
ROCE (%)7.089.7317.9137.1937.3221.0610.42
Asset Turnover Ratio0.520.670.81.21.210.70.37
PAT to CFO Conversion(x)6.33242.170.640.410.191.01
Working Capital Days
Receivable Days4643556680100126
Inventory Days8763335
Payable Days45132025019017111091

Yatharth Hospital & Trauma Care Services Ltd Stock News

Yatharth Hospital & Trauma Care Services Ltd FAQs

The current trading price of Yatharth Hospital on 05-Dec-2025 12:04 is ₹678.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Yatharth Hospital stood at ₹6,595.9.
The latest P/E ratio of Yatharth Hospital as of 04-Dec-2025 is 71.76.
The latest P/B ratio of Yatharth Hospital as of 04-Dec-2025 is 4.19.
The 52-week high of Yatharth Hospital is ₹843.0 and the 52-week low is ₹345.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Yatharth Hospital is ₹489.8 ( Cr.) .

About Yatharth Hospital & Trauma Care Services Ltd

The company was incorporated as ‘Yatharth Hospital & Trauma Care Services Private Limited’ in Delhi as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated February 28, 2008, issued by the RoC. Pursuant to a special resolution passed by its Shareholders on November 3, 2021, the company was converted into a public limited company and consequently, the name of the company was changed to ‘Yatharth Hospital & Trauma Care Services Limited’ and a fresh certificate of incorporation dated November 18, 2021 was issued by the RoC.

The company’s hospitals (i.e., Noida Extension Hospital and Greater Noida) are the largest private hospital in the National Capital Region of Delhi (Delhi NCR), respectively, in terms of number of beds in Fiscal 2023. The company operates three super specialty hospitals located in Delhi NCR, i.e., at Noida, Greater Noida and Noida Extension, Uttar Pradesh. Further, it acquired a 305-bedded multi-speciality hospital in Orchha, Madhya Pradesh near Jhansi, Uttar Pradesh (Jhansi-Orchha) which commenced commercial operations in from April 10, 2022, and is one of the largest hospital in Jhansi-Orchha-Gwalior region in terms of number of beds. For better and more focussed patient care, the company has carved out the super specialty as Centres of Excellence (COE) namely Centre of Medicine, Centre of General Surgery, Centre of Cardiology, Centre of Neurosciences, Centre of Nephrology & Urology, Centre of Paediatrics, Centre of Pulmonology, Centre of Gynaecology, and Centre of Orthopaedics & Spine & Rheumatology. Establishing COEs involves equipping these specialties with (i) advanced medical infrastructure; (ii) trained and experienced doctors, nursing, paramedical and other staff; and (iii) resources to provide a better healthcare experience to the patient and attendants. The company’s COEs represent its top 10 revenue-generating specialties. Its COEs are led by a team of respective domain expert doctors who are ably assisted by other doctors in its pursuit of providing better healthcare services to its patients. Further, while it has have started bone marrow and kidney transplant operations at its hospitals located in Noida Extension and Greater Noida, it also intends to introduce new specialties such as radiation therapy to its oncology department at its hospitals located in Noida Extension and Jhansi-Orchha.

The company’s hospitals have been designed to comply with international quality standards. All its hospitals are accredited by the NABH while its hospitals located at Greater Noida and Noida Extension are also accredited by NABL. All of its hospitals offer spacious suites along with modern deluxe and super deluxe rooms, and comfortable patient waiting areas. Its diagnostic areas are designed with the goals of providing patient-friendly, spacious and relaxing environments. It has advanced medical equipment such as Azurion catheterization laboratory, 1.5 Tesla wholebody MRI with optical digital broadband and embedded express coil technology for minimal patient repositioning and advanced non-contrast MR Angiography, 128 slice CT scan, endo bronchial ultrasound, nerve conduction velocity (NCV), advanced surgical equipment including Thulium Uro laser, flexible scope, advance laparoscope, advance microscopes, Cusa set. The advanced equipments provide for better and more accurate diagnosis, as well as insight into the surgical procedure, which increases surgical success rate. Some of its modular operation theatres are equipped with high efficiency particulate air (HEPA) filters and laminar flow, operating microscopes with image intensifiers. Its in-house diagnostic radiology setup and diagnostic labs are well equipped centres with comprehensive diagnostic capabilities including, haematology, biochemistry, microbiology, molecular biology and histopathology along with 24x7 in-house pharmacy shops.

Business area of the company 

The company offers healthcare services across several specialties and super specialties.

Awards, accreditations & recognition

Accreditations

  • 2022: Certificate of hospital grading under the category ‘excellent’ from Infomerics Analytics & Research Pvt Ltd to the Greater Noida Hospital.
  • 2022: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers to the Jhansi-Orchha Hospital.
  • 2022: Certificate of accreditation (ISO 15189:2012) from National Accreditation Board for Testing and Calibration Laboratories for medical testing for the Noida Extension Hospital.
  • 2021: Certificate of accreditation from National Accreditation Board for Hospitals& Healthcare Providers to the Noida Extension Hospital.
  • 2020: Certificate of accreditation (ISO 15189:2012) from National Accreditation Board for Testing and Calibration Laboratories for molecular testing (RTPCR-Covid 19) for the Noida Extension Hospital.
  • 2017: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers to the Noida Hospital.
  • 2016: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers for the Greater Noida Hospital.

Awards

  • 2023: Awarded UP Ratan Samman by Dainik Jagran Inext.
  • 2021: 5 star grading by Infomerics Analysts & Research Private Limited for its hospitals located at Noida, Noida Extension and Greater Noida.
  • 2021: Covid Thank You Award by Niva Bupa.
  • 2021: Certificate of appreciation as ‘Heroes’-Beyond the Call of Duty from Tata Consultancy Services.
  • 2020: Awarded 1st Rank in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended September 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Awarded 1stPrize in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended June 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Recognized as Emerging Hospital Chain in Delhi NCR by Medico Trip India.

History and milestone 

  • 2010: Established its first hospital (i.e., Greater Noida Hospital).
  • 2013: Established its second hospital (i.e., NoidaHospital).
  • 2019: Commenced operations at its third hospital (i.e., Noida Extension Hospital) which was acquired in 2016 pursuant to acquisition of its Subsidiary, AKS.
  • 2022: Acquired fourth hospital (i.e., Jhansi-Orchha Hospital) pursuant to acquisition of its Subsidiary, Ramraja.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×